Equity Capital And Reserves تغییر دادن تاریخ
AbbVie USD 12.09B 772M 2023-09
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
Acorda Therapeutics USD 67.87M 9.09M 2023-06
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
ALKERMES USD 1.36B 75.15M 2023-09
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amgen USD 6.23B 1.42B 2023-12
Biogen USD 14.8B 315.6M 2023-12
BioMarin Pharmaceutical USD 4.95B 54.65M 2023-12
Cytokinetics USD -386323000 52.48M 2023-12
Dynavax Technologies USD 622.07M 17.16M 2023-12
Enanta Pharmaceuticals USD 216.74M 21.08M 2023-09
Exelixis USD 2.35B 180.32M 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
Halozyme Therapeutics USD 83.81M 165.37M 2023-12
Incyte USD 5.19B 258.39M 2023-12
Intra Cellular Therapies USD 591.42M 9.26M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Nektar Therapeutics USD 159.37M 37.59M 2023-09
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Repligen USD 1.97B 17.35M 2023-12
Rigel Pharmaceuticals USD -31834000 3.72M 2023-09
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Teva Pharmaceutical Industries USD 6.93B 122M 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09
Xoma USD 105.96M 4.16M 2023-09



Neurocrine Biosciences سرمایه و ذخایر - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2024.